SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-049436
Filing Date
2019-09-10
Accepted
2019-09-10 08:45:58
Documents
4
Period of Report
2019-09-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-18452_18k.htm 8-K 42511
2 EX-10.1 a19-18452_1ex10d1.htm EX-10.1 207944
3 EX-99.1 a19-18452_1ex99d1.htm EX-99.1 7039
4 GRAPHIC g184521mmi001.jpg GRAPHIC 3151
  Complete submission text file 0001104659-19-049436.txt   263299
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 191084340
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1